Jack van Hulst

Jack van Hulst

Presidente presso International Center in New York

85 anni
Health Technology
Commercial Services
Finance

Profilo

Mr. van Hulst is an Operating Partner of SK Capital Partners.
He has 39 years experience in the pharmaceutical industry, having served as President, USA, of Diosynth, owner and CEO of two generic pharmaceutical companies, and EVP of Mova Pharmaceutical Corporation.
He also led the Population Council’s successful efforts to gain FDA approval of a Women’s Health product.
He is a director and former CEO of Senesco Technologies, a director of Napo Pharmaceuticals and Hi-Tech Pharmacal, and a former director of Protein Sciences.
Mr. van Hulst has a law degree from the University of Utrecht, The Netherlands.

Posizioni attive di Jack van Hulst

SocietàPosizioneInizio
Presidente 18/02/2011
New Brunswick, Inc. Direttore/Membro del Consiglio 05/10/2010
Tutte le posizioni attive di Jack van Hulst

Precedenti posizioni note di Jack van Hulst

SocietàPosizioneFine
Presidente 28/08/2013
Corporate Officer/Principal 01/01/2005
Presidente 01/01/1996
Pennex Products Co., Inc. Presidente 01/01/1993
AKZO NOBEL N.V. Corporate Officer/Principal 01/01/1989
Vedi nel dettaglio l'esperienza di Jack van Hulst

Formazione di Jack van Hulst

University of Utrecht Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jack van Hulst

Relazioni

34

Relazioni di 1° grado

13

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
AKZO NOBEL N.V.

Process Industries

Aziende private11

Health Technology

Commercial Services

Health Technology

Diosynth, Inc.

Health Technology

Health Technology

Pennex Products Co., Inc.

Commercial Services

Finance

New Brunswick, Inc.

Miscellaneous

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Jack van Hulst